Rocket Pharmaceuticals

Seeking #GeneTherapy cures for patients with rare and devastating diseases.

[Rocket Pharmaceuticals @RocketPharma]

#TeamRocket is at @escardio’s #HeartFailure26, engaging with the cardiovascular community to share our #GeneTherapy research and build ongoing relationships aimed at earlier diagnosis, advancing research, and strengthening collaboration in addressing inherited cardiomyopathies.

[Rocket Pharmaceuticals @RocketPharma]

#TeamRocket is heading to the @ASGCTherapy Annual Meeting next week!  We look forward to connecting with experts on the latest in #GeneTherapy for rare cardiovascular diseases.

#ASGCT2026

[Rocket Pharmaceuticals @RocketPharma]

#TeamRocket is attending @escardio’s upcoming Heart Failure 2026 Congress, where we will connect with experts on rare cardiovascular diseases. Join us on May 11th at 3:30 CEST for a presentation on our AAV gene therapies for genetic cardiomyopathies.

#HeartFailure26

[Rocket Pharmaceuticals @RocketPharma]

#TeamRocket is heading to Rome for the ARM Cell & Gene Therapy Meeting on the Med! Our CEO, Gaurav Shah, MD, will be joining a panel about removing barriers in cell and gene therapy.

We look forward to engaging with the regenerative medicine community about our #GeneTherapy solutions for rare cardiovascular diseases.

[Rocket Pharmaceuticals @RocketPharma]

#TeamRocket is heading to @hrsonline’s Heart Rhythm 2026 to discuss the latest in cardiovascular care and research with fellow leaders in the field. As we advance our #GeneTherapy pipeline for rare genetic heart conditions, including #DanonDisease, we look forward to connecting with the #cardiovascular community.

#HRS2026

[Rocket Pharmaceuticals @RocketPharma]

#NEWS: Rocket Pharmaceuticals today announced the U.S. FDA approval of the first #GeneTherapy for pediatric patients with severe Leukocyte Adhesion Deficiency-I (LAD-I).

More: https://t.co/YrJuWo1r3J

[Rocket Pharmaceuticals @RocketPharma]

#TeamRocket is at @ACCinTouch 2026 Annual Scientific Sessions engaging with leading cardiologists about researching genetic medicines for the heart — including our #GeneTherapy pipeline for #DanonDisease & other rare genetic heart conditions.

Learn more:  https://t.co/RIdsRMMLgV

[Rocket Pharmaceuticals @RocketPharma]

Last month, we celebrated #RareDiseaseDay—but for #TeamRocket and the rare disease community, advocacy continues throughout the whole year.

Rocket is proud to work alongside advocates like the @EveryLifeOrg for Rare Diseases in our shared mission to bring transformative treatments to patients with rare diseases.

Check out these photos of our team at our Rare Disease advocacy events last month. ⬇️

[Rocket Pharmaceuticals @RocketPharma]

At 12 pm ET tomorrow,hear Donald B. Kohn, MD and Jordan Orange, MD discuss #GeneTherapy for inborn errors of immunity as part of @Info4PI’s Speaker Series.

Register here: https://t.co/qvnzK3tLb0

[Rocket Pharmaceuticals @RocketPharma]

#TeamRocket is presenting at the 2026 Primary Immune Deficiency Treatment Consortium Annual Workshop. Join us on 3/19 at 4:20 pm MT to hear more about LAD-I.

Learn more about our science:  https://t.co/tQ4B09ftUy

[Rocket Pharmaceuticals @RocketPharma]

Happy #InternationalWomensDay! This year's theme #GiveToGain speaks to everything #TeamRocket believes in. When we give our knowledge, support, & mentorship to those around us, we all gain.

Celebrating the women advancing therapies for rare #cardiovasculardiseases every day.

Learn more:  https://t.co/l39fkop1S8

[Rocket Pharmaceuticals @RocketPharma]

This #RareDiseaseDay, Rocket stands with the 300+ million people living with #RareDiseases. We’re proud to join @rarediseases in #LightUpforRare & continue our pursuit of a world where DNA is no longer destiny.
Learn more about our commitments: https://t.co/l39fkop1S8

@NasdaqExchange

[Rocket Pharmaceuticals @RocketPharma]

#TeamRocket is proud to have participated in #RareDC2026, supporting @EveryLifeOrg’s event that brings together patients, caregivers, advocates, policymakers and more to advance solutions for the #RareDisease community.

[Rocket Pharmaceuticals @RocketPharma]

#TeamRocket is proud to sponsor the @globeevents Rare Disease Summit tmrw! Join us in-person or virtually to hear patient stories, learn about advances in research & connect w/the #RareDisease community.

Register: https://t.co/s8a9VebZpL

[Rocket Pharmaceuticals @RocketPharma]

At Rocket, our Mission: Genome program provides sponsored, no-charge genetic counseling and testing for people with a family history or suspected diagnosis of certain genetic conditions.

Learn more: https://t.co/5osqJnNoVF

[Rocket Pharmaceuticals @RocketPharma]

Rocket is proud to sponsor the @globeevents Rare Disease Summit, coming up on 2/24 & bringing together the #raredisease community.

Register now to attend in-person or virtually: https://t.co/s8a9Vecxfj

[Rocket Pharmaceuticals @RocketPharma]

#TeamRocket is heading to San Francisco to present at the J.P. Morgan 44th Annual Healthcare Conference. We’re looking forward to connecting with industry leaders and innovators to discuss the future of #genetherapy from January 12 – 15.

More: https://t.co/6er45tkPsn

#JPM2026

[Rocket Pharmaceuticals @RocketPharma]

Happy New Year from #TeamRocket! 🎉 We remain committed to advancing #genetherapy for rare genetic diseases in 2026. To everyone who contributed to our mission this past year—thank you. Your dedication makes a difference for the #raredisease communities we serve.

[Rocket Pharmaceuticals @RocketPharma]

#TeamRocket is heading to Lisbon for @escardio's Cardio Genomics Meeting! Looking forward to connecting on the latest in cardiovascular genomics & #genetherapy for inherited heart conditions.

Learn more: https://t.co/4fdQPpxFBt

#ESCGenomics2025

[Rocket Pharmaceuticals @RocketPharma]

Happy Thanksgiving from #TeamRocket! We’re grateful for our team's passion for #genetherapy and the patients who inspire our mission.

Wishing everyone a safe and wonderful Thanksgiving! 🦃